Related Experiment Videos
Bilirubin removal from a jaundiced premature infant by resin hemoperfusion
ASAIO Transactions
|July 1, 1986
Insights
Hemoperfusion successfully removed bilirubin in a premature infant without adverse effects. This innovative technique offers a promising alternative to blood exchange for treating newborn jaundice.
Area of Science:
- Neonatal Medicine
- Pediatric Nephrology
- Critical Care Medicine
Background:
- Neonatal hyperbilirubinemia is a common condition in premature infants.
- Traditional treatments like phototherapy may be insufficient in severe cases.
- Blood exchange transfusion carries significant risks for vulnerable newborns.
Abstract:
To summarize the results: Bilirubin removal by hemoperfusion was successfully performed for the first time on a premature infant. The hemoperfusion caused no adverse effects on the clinical state of the infant. The bilirubin removed in 90 min--13 mg--indicates the existence of a large extravascular pool. Hemoperfusion is suggested for bilirubin removal from newborn babies, reducing the need for blood exchange with bank blood.